Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility

被引:0
作者
Hidetaka Okubo
Junichi Akiyama
Masao Kobayakawa
Megumi Kawazoe
Saori Mishima
Yusuke Takasaki
Naoyoshi Nagata
Takayuki Shimada
Chizu Yokoi
Shiori Komori
Kana Kimura
Yuya Hisada
Eri Iwata
Kazuhiro Watanabe
Naohiro Yanagisawa
Sho Shiroma
Akira Shimomura
Koki Okahara
Hourin Cho
Naomi Uemura
机构
[1] National Center for Global Health and Medicine,Division of Gastroenterology and Hepatology
来源
Journal of Gastroenterology | 2020年 / 55卷
关键词
Vonoprazan; eradication; Clarithromycin resistance; Triple therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1054 / 1061
页数:7
相关论文
共 124 条
[1]  
Moss SF(2016)The clinical evidence linking Cell Mol Gastroenterol Hepatol. 3 183-191
[2]  
Dang BN(2017) to gastric cancer Nat Rev Gastroenterol Hepatol. 14 383-384
[3]  
Graham DY(2016) infection and antibiotic resistance: a WHO high priority? Aliment PharmacolTher. 43 514-533
[4]  
Thung I(2015)Review article: the global emergence of Gut 64 1353-1367
[5]  
Aramin H(2014) antibiotic resistance World J Gastroenterol 20 5283-5293
[6]  
Vavinskaya V(2016)Kyoto global consensus report on J Gastrointestin Liver Dis. 25 283-288
[7]  
Sugano K(2016) gastritis Dig Dis Sci 61 3215-3220
[8]  
Tack J(2016)Treatment of Therap Adv Gastroenterol. 9 845-852
[9]  
Kuipers EJ(2010) infection: current status and future concepts J Pharmacol Exp Ther 335 231-238
[10]  
Yang JC(2016)A novel potassium-competitive acid blocker improves the efficacy of clarithromycin-containing 7-day triple therapy against Gut 65 1439-1446